BIZ PRESS – The DNA testing firm 23andMe continues to struggle after declaring bankruptcy in late March, though courts have cleared the way for Regeneron Pharmaceuticals to buy the company, which has lost millions of dollars since its heyday in 2021. Officials originally blamed the bankruptcy on weak demand and fallout from a data breach, but internal audits have revealed that more than half of all American men who visited the company’s website mistakenly believed it was a discussion forum focused on their lifelong personal devotion to Michael Jordan.
